Stéphane Goutagny Selected Research

Stéphane Goutagny Research Topics

6	Neoplasms (Cancer) 01/2019 - 09/2010
5	Meningioma (Meningiomas) 01/2022 - 10/2006
4	Acoustic Neuroma (Acoustic Neurinoma) 06/2017 - 06/2013
3	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2016 - 06/2013
2	Brain Injuries (Brain Injury) 02/2022 - 01/2021
1	Coma (Comas) 02/2022
1	Intracranial Hypertension 02/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Post-Dural Puncture Headache 01/2021
1	Disease Progression 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Schwannomatosis 01/2018

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
3	Everolimus FDA Link 06/2017 - 04/2015
2	ElementsIBA 01/2021 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2016 - 04/2015
1	barbituric acid (barbiturate)IBA 02/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	ChromatinIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Vascular Endothelial Growth FactorsIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2015
1	Neurofibromin 2 (Merlin)IBA 04/2015